Literature DB >> 8420285

Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature.

A R Tunkel1, C Y Thomas, B Wispelwey.   

Abstract

Prosthetic arthritis due to Candida species is uncommon, with only 15 cases reported in the literature. We recently cared for a human immunodeficiency virus-infected patient who developed Candida parapsilosis prosthetic arthritis unresponsive to resection arthroplasty, intravenous amphotericin B, and suppressive ketoconazole therapy. Treatment with fluconazole led to mycologic cure and symptom improvement, although he subsequently underwent above-the-knee amputation due to continued joint instability. Fluconazole may be useful follow-up therapy after a course of amphotericin B combined with resection arthroplasty or when removal of the prosthesis cannot be accomplished.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420285     DOI: 10.1016/0002-9343(93)90127-b

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer.

Authors:  Meng-Huang Wu; Kuo-Yao Hsu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-07-22       Impact factor: 4.342

3.  Brucellar prosthetic arthritis in a total knee replacement.

Authors:  A Ortí; P Roig; R Alcalá; V Navarro; M Salavert; C Martín; A Zorraquino; J Merino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

Review 4.  Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature.

Authors:  G Weers-Pothoff; J F Havermans; J Kamphuis; H A Sinnige; J F Meis
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

Review 5.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

6.  Candida periprosthetic infection of the knee: a systematic review of surgical treatments and clinical outcomes.

Authors:  Federico Fusini; Gabriele Colò; Alessandro Rava; Luigi Sabatini; Alessandro Massè; Alessandro Aprato; Stefano Artiaco
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-02-19

Review 7.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 8.  Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?

Authors:  Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Scand J Infect Dis       Date:  2010

9.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

10.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.